X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-11-11 | NUVB | Wang Junyuan Jerry | CEO, ANHEART THERAPEUTICS LTD. | S - Sale | $2.89 | -56,361 | 6,112,686 | -1% | -$162,883 | ||||||
2024-10-08 | NUVB | Mashal Robert | Dir | P - Purchase | $2.20 | +100,000 | 100,000 | New | +$220,000 | ||||||
2024-06-25 | NUVB | Cui Xiangmin | Dir | P - Purchase | $2.97 | +277,895 | 6,950,239 | +4% | +$825,348 | ||||||
| M | 2024-06-20 | NUVB | Cui Xiangmin | Dir | P - Purchase | $2.98 | +500,000 | 6,672,344 | +8% | +$1,492,385 | |||||
2024-06-11 | NUVB | Blickenstaff Kim D | Dir | P - Purchase | $2.90 | +172,189 | 172,189 | New | +$500,089 | ||||||
| AM | 2023-09-19 | NUVB | Nodelman Oleg | Dir | P - Purchase | $1.26 | +5,313,100 | 12,674,775 | +72% | +$6,692,265 | |||||
| M | 2023-02-19 | NUVB | Nodelman Oleg | Dir | P - Purchase | $1.26 | +5,313,100 | 19,209,643 | +38% | +$6,692,265 | |||||
| M | 2022-11-30 | NUVB | Falberg Kathryn E | Dir | P - Purchase | $1.94 | +250,000 | 250,000 | New | +$483,836 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |